Performance Period: 2/1/2019 to 7/31/2019
The purpose of the Merck-NJII Biopharmaceutical Training Acceleration Proposal (BTAP) is to provide funding for the development of a training program to enable incumbent employees in the biopharmaceutical industry to acquire competencies in the bioprocess development and manufacturing operations related to the biologics field. The proposal is led by Haro Hartounian, Ph.D. of the New Jersey Innovation Institute. He will serve as both the PI and the Project Manager. Steve Dziennik, Ph.D. and Kelly Woltornist of Merck will serve as co-PIs.
Training plan and curriculum that is vetted by industry for setting industry training standards
Establishment of proficiency levels for development and technology professionals in each modality
Rapid retraining of incumbent employees to prepare them to move across multiple technical areas
Login to the NIIMBL member portal to access more, including:
Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.
New Jersey Innovation Institute
Merck Sharp & Dohme LLC
